A phase II open-label study of aprepitant as anti-emetic prophylaxis in patients with acute myeloid leukemia (AML) undergoing induction chemotherapy.
Acute myeloid leukemia
Anti-emetics
Chemotherapy
Neurokinin inhibitors
Journal
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
ISSN: 1433-7339
Titre abrégé: Support Care Cancer
Pays: Germany
ID NLM: 9302957
Informations de publication
Date de publication:
Jun 2019
Jun 2019
Historique:
received:
04
05
2018
accepted:
12
10
2018
pubmed:
21
10
2018
medline:
22
6
2019
entrez:
21
10
2018
Statut:
ppublish
Résumé
Despite the widespread use of 5-HT
Identifiants
pubmed: 30341536
doi: 10.1007/s00520-018-4515-4
pii: 10.1007/s00520-018-4515-4
doi:
Substances chimiques
Antiemetics
0
Aprepitant
1NF15YR6UY
Types de publication
Clinical Trial, Phase II
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2295-2300Références
Biol Blood Marrow Transplant. 2001;7(11):596-603
pubmed: 11760147
Cancer. 2003 Jun 15;97(12):3090-8
pubmed: 12784346
J Clin Oncol. 2003 Nov 15;21(22):4112-9
pubmed: 14559886
J Clin Oncol. 2005 Feb 20;23(6):1289-94
pubmed: 15718327
Cancer. 2005 May 15;103(10):2082-90
pubmed: 15830348
J Clin Oncol. 2005 Apr 20;23(12):2822-30
pubmed: 15837996
J Clin Oncol. 2006 Sep 20;24(27):4472-8
pubmed: 16983116
J Cell Physiol. 1991 Jul;148(1):60-7
pubmed: 1860896
J Clin Oncol. 2012 Nov 10;30(32):3998-4003
pubmed: 22915652
J Clin Oncol. 2014 Oct 20;32(30):3413-20
pubmed: 25225424
Int J Hematol. 2015 Apr;101(4):376-85
pubmed: 25644148
Biomed Res Int. 2015;2015:497597
pubmed: 25654108
Ann Oncol. 2016 Sep;27(suppl 5):v119-v133
pubmed: 27664248
Haematologica. 2018 Jun;103(6):988-998
pubmed: 29519869
Br J Cancer. 1997;76(8):1055-61
pubmed: 9376266